Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraocular Concentrations of Growth Factors and Cytokines in Chronic Central Serous Chorioretinopathy And the Effect of Therapy With Bevacizumab

NCT00864773 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.

NCT NCT00864773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00864773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraocular Concentrations of Growth Factors and Cytokines in Chronic Central Serous Chorioretinopathy And the Effect of Therapy With Bevacizumab
Lead sponsor
Hallym University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2009
Completion date
March 31, 2010
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

central serous chorioretinopathy